ArticleBiomedicines2021

Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery.

Jielin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.